Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 1:55 PM UTC
| NCT Number | NCT06253130 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 156 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Eikon Therapeutics |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of July 20, 2026: Clinical trial NCT06253130 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 23 locations across the United States. The study is sponsored by Eikon Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06253130 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06253130 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.